Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

LENZ Therapeutics (LENZ) EBT Margin (2025)

LENZ Therapeutics (LENZ) has disclosed EBT Margin for 1 consecutive years, with 2260.33% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 2260.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 427.57% through Dec 2025, changed N/A year-over-year, with the annual reading at 427.62% for FY2025, N/A changed from the prior year.
  • EBT Margin for Q4 2025 was 2260.33% at LENZ Therapeutics, down from 133.6% in the prior quarter.
  • The five-year high for EBT Margin was 133.6% in Q3 2025, with the low at 2260.33% in Q4 2025.